Moleculin Biotech
MBRX • NASDAQ
Moleculin Biotech is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Walter V. Klemp, with a market cap of $13.0M.
Market Cap$13.0M
Employees18.0
CEOWalter V. Klemp
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 12, 2026 · in a monthQ1 2026
Financials
Moleculin Biotech FAQ
Common questions about Moleculin Biotech
Moleculin Biotech is scheduled to report earnings for Q1 2026 on May 12, 2026.
Moleculin Biotech has approximately 18 employees.